NeuroMetrix, Inc. (Nasdaq: NURO) held its first Quell ® Wearable Pain Relief Technology™ user event last Thursday, April 27. As a customer-focused company, NeuroMetrix frequently looks to its users to inform product updates and innovation.

NeuroMetrix welcomed a group of 30 Quell users to its Waltham headquarters to "meet the makers," learn about upcoming Quell product features, share their stories, and give feedback on the product. Quell users learned about product development directly from Shai N. Gozani, M.D., Ph.D., President and CEO at NeuroMetrix, and connected with peers and NeuroMetrix's customer care, engineering, and marketing teams.

"We know that Governor Baker's goal is to establish Massachusetts as a digital health hub and we are proud to contribute to that mission as a Massachusetts-based digital health company," said Frank McGillin, Senior Vice President and Chief Commercial Officer at NeuroMetrix. "Many of those living with chronic pain in the Commonwealth have been reliant on medication to manage their day-to-day pain. Hearing that Quell has enabled many of the event's attendees to reduce or eliminate their use of opioids was a rewarding experience. We look forward to hosting more of these events in the future."

Attendees had the opportunity to share their experiences and discuss how Quell has changed their approach to pain management. "I did not know what it was like to live life without pain, until I got my Quell," said one attendee. Another Quell user stated, "Quell has returned my freedom to choose what I want to do daily, not what my pain will let me do today. I have my life back again!"

While Quell provides an opportunity to reduce drug reliance, the reality is that many chronic pain sufferers will require some degree of continued usage of medications to deal with their pain. NeuroMetrix believes a "treatment toolbox" approach that looks to supplement pain medications with technology and other alternatives may be effective in many cases.

If you liked this article you might like

The 7 Most Intriguing Products We Saw at CES

NeuroMetrix (NURO) Stock Gains After Launching Diabetes Test in Mexico

Insider Trading Alert - CMPR, AER And NURO Traded By Insiders

Insider Trading Alert - SKT, HEB And NURO Traded By Insiders

5 Breakout Stocks Under $10 Set to Soar